Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

May 27, 2025

Study Completion Date

October 27, 2027

Conditions
NSCLCIMMUNOTHERAPYQUANTIFICATION OF CELL-FREE DNA
Interventions
GENETIC

Molecular monitoring by quantification of cell-free DNA

"Molecular monitoring by quantification of cell-free DNA (absolute value and variation from baseline) of two house-keeping genes (RPP30, TMEM11) by droplet digital PCR, during based-immunotherapy treatments of NSCLC patients.~Cell-free DNA will be extracted from 4 ml of plasma before treatments by immunotherapy, obtained from blood Streck® tubes.~Quantification of house-keeping genes (or mutated genes if some are previously routinely identified in tumor tissue) by ddPCR."

Trial Locations (8)

Unknown

RECRUITING

CHU de Besancon - Service de pneumologie, Besançon

RECRUITING

Hopitaux Civils de Colmar - service de Pneumologie, Colmar

RECRUITING

CHU de Dijon - service de Pneumologie, Dijon

NOT_YET_RECRUITING

CLCC Georges-François Leclerc, Dijon

RECRUITING

GHR Mulhouse Sud-Alsace - Service de Pneumologie, Mulhouse

RECRUITING

CHU de Reims - service de Pneumologie, Reims

RECRUITING

CHRU de Strasbourg, Strasbourg

RECRUITING

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER